Profile
Robert J.
Israel worked as an Associate Director-Oncology Clinical Research at Schering-Plough Corp.
from 1988 to 1991.
He then worked as a Director-Clinical Research-Oncology at Sandoz Pharmaceuticals Corp.
from 1991 to 1994.
From 1994 to 2015, he worked at Progenics Pharmaceuticals, Inc. as an Executive Vice President-Innovation.
Dr. Israel holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers State University of New Jersey.
Former positions of Robert J. Israel
| Companies | Position | End |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-07-01 |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | 1993-12-31 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 1990-12-31 |
Training of Robert J. Israel
| University of Pennsylvania | Doctorate Degree |
| Rutgers State University of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Stock Market
- Insiders
- Robert J. Israel
